galantamine has been researched along with choline in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyle, JT; Puttfarcken, PS; Sweeney, JE | 1 |
| Albuquerque, EX; Alkondon, M; Hilmas, C; Maelicke, A; Pereira, EF; Santos, MD | 1 |
| CHAO, JL; CHAO, KC; HU, CC | 1 |
| Akk, G; Steinbach, JH | 1 |
| Carelli, V; Costa, N; De Vita, D; Liberatore, F; Marra, R; Rispoli, V; Rotiroti, D; Scipione, L | 1 |
| Albuquerque, EX; Lopes, C; Maelicke, A; Pereira, EF; Popa, RV | 1 |
| Albuquerque, EX; Lopes, C; Njar, V; Pereira, EF; Purushottamachar, P; Schwarcz, R; Wu, HQ | 1 |
| Shimohama, S | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C | 1 |
| Bartha, R; Borrie, MJ; Penner, J; Rupsingh, R; Smith, M; Wells, JL | 1 |
| Deckersbach, T; Iosifescu, DV; Moore, CM; Nierenberg, AA; Ostacher, MJ; Sachs, GS; Tilley, CA | 1 |
| Fujikawa, Y; Kagitani, S; Kitamura, R; Kitamura, Y; Maelicke, A; Saeki, M; Shimohama, S; Takata, K; Taniguchi, T; Terada, M; Tomimoto, H | 1 |
| Al-Onaizi, MA; Barbash, S; Bartha, R; Guzman, MS; Hirata, PH; Kolisnyk, B; Nikolova, S; Prado, MA; Prado, VF; Soreq, H | 1 |
| Bogdanov, MG; Svinyarov, I | 1 |
3 review(s) available for galantamine and choline
| Article | Year |
|---|---|
Unconventional ligands and modulators of nicotinic receptors.
Topics: Amyloid beta-Peptides; Anesthetics; Animals; Choline; Galantamine; Hallucinogens; Humans; Kynurenic Acid; Ligands; Receptors, Nicotinic; Serotonin; Steroids | 2002 |
[Treatment of Alzheimer's disease: status quo and future considerations].
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Behavioral Symptoms; Choline; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Design; Galantamine; Glutamic Acid; Humans; Indans; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Risk Factors; Rivastigmine | 2008 |
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.
Topics: Alkanes; Alzheimer Disease; Amides; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anisoles; Antioxidants; Aspartic Acid Endopeptidases; Attention; Choline; Drug Design; Ethylamines; Galantamine; Humans; Memory; Neurons; Phosphorylation; Plaque, Amyloid; Platelet Aggregation Inhibitors; tau Proteins | 2009 |
2 trial(s) available for galantamine and choline
| Article | Year |
|---|---|
Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain Mapping; Choline; Cholinesterase Inhibitors; Creatine; Female; Galantamine; Glutamic Acid; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Neuropsychological Tests; Regression Analysis | 2010 |
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Bipolar Disorder; Brain Mapping; Choline; Cholinesterase Inhibitors; Cognition Disorders; Female; Galantamine; Humans; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Protons; Young Adult | 2009 |
9 other study(ies) available for galantamine and choline
| Article | Year |
|---|---|
Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Basal Ganglia; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Galantamine; Hemicholinium 3; Male; Mice; Mice, Inbred BALB C; Motor Activity; Psychomotor Performance; Quinuclidinyl Benzilate; Time Factors | 1989 |
[THE EFFECT OF GALANTHAMINE AND LYCORAMINE ON THE CHOLINE REACTIVE SYSTEM].
Topics: Alkaloids; Amaryllidaceae Alkaloids; Choline; Galantamine; Parasympathomimetics; Pharmacology; Research | 1965 |
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
Topics: Acetylcholine; Action Potentials; Allosteric Regulation; Amino Acid Substitution; Animals; Binding Sites; Bungarotoxins; Carbachol; Cell Line; Choline; Cholinesterase Inhibitors; Fetal Proteins; Galantamine; Humans; Ion Channel Gating; Kidney; Ligands; Mice; Muscle Proteins; Mutation, Missense; Nicotinic Agonists; Patch-Clamp Techniques; Point Mutation; Protein Structure, Tertiary; Protein Subunits; Receptors, Nicotinic; Recombinant Fusion Proteins | 2005 |
Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged rats.
Topics: Animals; Behavior, Animal; Choline; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electroencephalography; Enzyme Inhibitors; Galantamine; Male; Rats; Rats, Wistar; Scopolamine; Tacrine | 2006 |
The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Culture Techniques; Choline; Evoked Potentials; Galantamine; Hippocampus; Ligands; Neurons; Patch-Clamp Techniques; Receptors, Nicotinic | 2006 |
Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Atropine; Cells, Cultured; Choline; Corpus Striatum; Dopamine; Galantamine; Kynurenic Acid; Male; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2007 |
Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Binding Sites; Calcium Signaling; Calmodulin; Cells, Cultured; Choline; Cholinesterase Inhibitors; Disease Models, Animal; Female; Galantamine; Hippocampus; Humans; Male; Microglia; Nootropic Agents; Phagocytosis; Rats; Rats, Wistar; Receptors, Nicotinic | 2010 |
Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.
Topics: Acetylcholine; Animals; Aspartic Acid; Choice Behavior; Choline; Cholinesterase Inhibitors; Cognition Disorders; Executive Function; Galantamine; Inositol; Lactic Acid; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Photic Stimulation; Prefrontal Cortex; Psychomotor Performance; RNA Splicing; Taurine; Vesicular Acetylcholine Transport Proteins | 2013 |
Analysis of acetylcholinesterase inhibitors by extraction in choline saccharinate aqueous biphasic systems.
Topics: Alkaloids; Anions; Choline; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Compounding; Galantamine; Humans; Hydrogen-Ion Concentration; Ionic Liquids; Liquid-Liquid Extraction; Pharmaceutical Preparations; Temperature; Water | 2018 |